Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Ali Faraz, holds the title of Chief Executive Officer at Tenaya Therapeutics, Inc..
On 2026-11-17, the insider transacted 3,499 shares.The shares were transacted at a weighted average price of $0.32 per share, resulting in a total market-relevant value of $1K.
Ali Faraz (Chief Executive Officer) sold $1K of $TNYA
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.